Clinical Roundup Trisalus pressure-enabled drug delivery increased effect of anti-CEA CAR-T in pancreatic cancer patients with liver metastases November 09, 2018Vol.44 No.42
In Brief Richard M. Schulze Family Foundation gives $6 million to Moffitt November 09, 2018Vol.44 No.42
In Brief Paul G. Allen Frontiers Group announces Allen Distinguished Investigators November 09, 2018Vol.44 No.42
Conversation with The Cancer Letter Jaffee: Congressional commitment to NIH will continue through FY2021 November 09, 2018Vol.44 No.42By Paul Goldberg
Conversation with The Cancer Letter Brawley: “I started out talking about black-and-white disparities, and now I write papers talking about state-by-state disparities” November 09, 2018Vol.44 No.42By Paul Goldberg
Otis Brawley leaves the American Cancer Society as it pursues “open-for-business” strategy amid sliding revenues November 09, 2018Vol.44 No.42By Paul Goldberg
Drugs & Targets FDA accepts sNDA for Lonsurf for metastatic gastric/gastroesophageal junction adenocarcinoma; grants Priority Review October 26, 2018Vol.44 No.40
Drugs & Targets BMS provides update on regulatory review of Opdivo + Yervoy in first-line lung cancer October 26, 2018Vol.44 No.40
Drugs & Targets Zai Lab announces approval of Zejula in relapsed ovarian cancer in Hong Kong October 26, 2018Vol.44 No.40
